TABLE 1.
Summary-of-findings Table on Mortality and Omphalitis
| Illustrative Comparative Risks |
||||||
|---|---|---|---|---|---|---|
| Outcomes | Assumed Risk |
Corresponding Risk |
Relative Effect (95% CI) |
No. of Participants (Studies) |
Quality of the Evidence (GRADE) |
Comments |
| Dry Care | Antimicrobials | |||||
| Neonatal mortality number of deaths within 28 d |
26 per 1000 | 23 per 1000 (21–26) | RR 0.88 (0.79–0.99) | 44,818 (3 studies) | ⊕⊕⊕⊕ high* | |
| Follow-up: mean 28 d | ||||||
| Omphalitis number of omphalitis cases |
108 per 1000 | 84 per 1000 (81–88) | RR 0.78 (0.75–0.81) | 44,600 (3 studies) | ⊕⊕⊕⊕⊖ moderate* | |
| Follow-up: mean 28 d | ||||||
Antimicrobials compared with dry care for umbilical cord care.
Patient or population: patients with umbilical cord care
Settings: community
Intervention: antimicrobials
Comparison: dry care
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
Study setting: Asia.